Conditions: Healthy
Keywords: bioavailability, capsule, tablet, healthy volunteer
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 24
Healthy volunteers: yes

Brief summary:
The study will be an open-label, randomized, 2-period, 2-treatment, 2-sequence, cross-over, single-dose study employing administration of two PF-02341066 formulations in the fasted state to healthy adult volunteers.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: PF-02341066 intervention 2: PF-02341066
Intervention descriptions: intervention 1: A 250-mg single dose of PF-02341066 administered as 1 x 50-mg Powder-in-Capsule and 2 x 100-mg Powder-in-Capsules intervention 2: A 250-mg single dose of PF-02341066 administered as 1 x 50-mg Immediate Release Tablet and 2 x 100-mg Immediate Release Tablets

Protocol document: